Product Information
LEVALBUTEROL 0.63 MG/3 ML SOL is a generic product labeled by Ritedose Pharmaceuticals, LLC, priced at $0.3124 per ML under NDC 76204080001. Its NADAC has been published 381 times since Jun 19, 2019.
FDA first approved this application on Mar 22, 2016. Its Orange Book therapeutic-equivalence code is AN.
Strength
.63 mg/3mL
Manufacturer
Ritedose Pharmaceuticals, LLCNDC
76204080001
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
LEVALBUTEROL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203653FDA Approved
3/22/2016
TE Code
AN
On Market Since
3/22/2016
Pharmacological Classes
Price Statistics
The NADAC for LEVALBUTEROL 0.63 MG/3 ML SOL has been published 381 times since Jun 19, 2019, and over the history we have for it it has risen 18.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3124 per ML |
|---|---|
| All-time high | $0.4468 (Jun 16, 2021) |
| All-time low | $0.2210 (Nov 20, 2024) |
| 52-week high | $0.3735 |
| 52-week low | $0.3124 |
| Median price | $0.3593 |
| Average price | $0.3473 |
| Largest weekly change | -39.4% (Nov 20, 2024) |
| Weeks tracked | 381 |
| Tracking since | Jun 19, 2019 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ritedose Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levalbuterol Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta2-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVALBUTEROL 0.63 MG/3 ML SOL?
The current National Average Drug Acquisition Cost (NADAC) for LEVALBUTEROL 0.63 MG/3 ML SOL, manufactured by Ritedose Pharmaceuticals, LLC, is $0.3124 per ML (NDC 76204080001), effective Sep 30, 2026.
How has the price of LEVALBUTEROL 0.63 MG/3 ML SOL changed over time?
Over the history we have for it, the NADAC for LEVALBUTEROL 0.63 MG/3 ML SOL has risen 18.5%. It has been tracked across 381 weekly CMS publications since Jun 19, 2019.
What are the highest and lowest recorded NADAC prices for LEVALBUTEROL 0.63 MG/3 ML SOL?
Since Jun 19, 2019, the NADAC for LEVALBUTEROL 0.63 MG/3 ML SOL has ranged from a low of $0.2210 (Nov 20, 2024) to a high of $0.4468 (Jun 16, 2021), with a median of $0.3593 per ML.
Are there cheaper alternatives to LEVALBUTEROL 0.63 MG/3 ML SOL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVALBUTEROL 0.63 MG/3 ML SOL, is $0.2480 per ML — about 21% below LEVALBUTEROL 0.63 MG/3 ML SOL.
Who manufactures LEVALBUTEROL 0.63 MG/3 ML SOL?
LEVALBUTEROL 0.63 MG/3 ML SOL (NDC 76204080001) is labeled by Ritedose Pharmaceuticals, LLC, and CMS classifies it as a generic product.